UNIGE document Scientific Article
previous document  unige:89762  next document
add to browser collection

CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation

Golshayan, D
Venetz, J-P
Manuel, O
Kutalik, Z
show hidden authors show all authors [1 - 19]
Published in The Pharmacogenomics Journal. 2017, vol. 17, no. 1, p. 69-75
Abstract Metabolic syndrome after transplantation is a major concern following solid organ transplantation (SOT). The CREB-regulated transcription co-activator 2 (CRTC2) regulates glucose metabolism. The effect of CRTC2 polymorphisms on new-onset diabetes after transplantation (NODAT) was investigated in a discovery sample of SOT recipients (n1=197). Positive results were tested for replication in two samples from the Swiss Transplant Cohort Study (STCS, n2=1294 and n3=759). Obesity and other metabolic traits were also tested. Associations with metabolic traits in population-based samples (n4=46'186, n5=123'865, n6>100,000) were finally analyzed. In the discovery sample, CRTC2 rs8450-AA genotype was associated with NODAT, fasting blood glucose and body mass index (Pcorrected<0.05). CRTC2 rs8450-AA genotype was associated with NODAT in the second STCS replication sample (odd ratio (OR)=2.01, P=0.04). In the combined STCS replication samples, the effect of rs8450-AA genotype on NODAT was observed in patients having received SOT from a deceased donor and treated with tacrolimus (n=395, OR=2.08, P=0.02) and in non-kidney transplant recipients (OR=2.09, P=0.02). Moreover, rs8450-AA genotype was associated with overweight or obesity (n=1215, OR=1.56, P=0.02), new-onset hyperlipidemia (n=1007, OR=1.76, P=0.007), and lower high-density lipoprotein-cholesterol (n=1214, β=-0.08, P=0.001). In the population-based samples, a proxy of rs8450G>A was significantly associated with several metabolic abnormalities. CRTC2 rs8450G>A appears to have an important role in the high prevalence of metabolic traits observed in patients with SOT. A weak association with metabolic traits was also observed in the population-based samples.The Pharmacogenomics Journal advance online publication, 8 December 2015; doi:10.1038/tpj.2015.82.
PMID: 26644205
Full text
This document has no fulltext available yet, but you can contact its author by using the form below.
Research groups Groupe Gasche-Soccal Paola (958)
Quorom-sensing et gènes de virulence (301)
Transplantation immunologie et osteoimmunologie (561)
(ISO format)
QUTEINEH, Lina et al. CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation. In: Pharmacogenomics journal, 2017, vol. 17, n° 1, p. 69-75. doi: 10.1038/tpj.2015.82 https://archive-ouverte.unige.ch/unige:89762

433 hits

0 download


Deposited on : 2016-12-02

Export document
Format :
Citation style :